Subcutaneous Immunoprophylaxis As A Cost-Effective Treatment Alternative For Hepatitis B Virus-Related Transplant Patients In France
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.2281
https://www.valueinhealthjournal.com/article/S1098-3015(17)32615-3/fulltext
Section Title :
Disease-Specific Studies
Section Order :
2101
First Page :
A783
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)32615-3&doi=10.1016/j.jval.2017.08.2281